MediGene, Inc.
10660 Scripps Ranch Blvd., Suite 200
San Diego
California
92121
United States
Tel: 858-586-2240
Fax: 858-362-3661
Website: http://www.medigene.com/
Email: careersusa@medigene.com
9 articles about MediGene, Inc.
-
BioNTech and Medigene announced a global agreement to develop T-cell immunotherapies against cancer. The three-year collaboration will focus on multiple solid tumor targets.
-
Licence Agreement for Innovative Co-Stimulator to Enhance Cell-Based Immunotherapy Against Cancer
1/9/2019
Ascenion Negotiated Additional Licence Agreement between Helmholtz Zentrum München and Medigene
-
MediGene, Inc. Announces Publication In Cancer Immunology, Immunotherapy On DC Vaccine Development For A Phase 1/2 Trial In Acute Myeloid Leukemia
10/16/2014
-
MediGene, Inc. Converts Immunocore Limited Shareholding Into Share Class With Upside Potential
6/24/2014
-
New CFO Arnd Christ To Take Up Position At MediGene, Inc. In April
4/19/2010
-
MediGene, Inc. Drug Extends Pancreatic Cancer Survival
9/16/2008
-
MediGene, Inc. Release: European Patent Granted on the Application of Anti-L1 Antibodies in Cancer Therapy
8/20/2008
-
Pfizer Inc. Eyes Germany's MediGene, Inc. According to Sources
5/14/2008
-
MediGene, Inc. To Present At The Ninth Annual Lehman Brothers' Global Healthcare Conference
3/2/2006